MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 94 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $730,000 | -95.7% | 179,078 | -93.3% | 0.00% | -95.1% |
| Q3 2016 | $16,855,000 | +12.7% | 2,654,373 | -4.3% | 0.04% | +13.9% |
| Q2 2016 | $14,953,000 | -33.1% | 2,774,321 | +3.9% | 0.04% | -32.1% |
| Q1 2016 | $22,356,000 | +27.5% | 2,670,971 | +20.3% | 0.05% | +32.5% |
| Q4 2015 | $17,537,000 | +166.4% | 2,219,926 | +186.9% | 0.04% | +166.7% |
| Q3 2015 | $6,584,000 | -30.7% | 773,666 | +0.7% | 0.02% | -21.1% |
| Q2 2015 | $9,496,000 | +3.9% | 767,978 | -0.2% | 0.02% | +5.6% |
| Q1 2015 | $9,142,000 | +4.0% | 769,545 | -1.0% | 0.02% | 0.0% |
| Q4 2014 | $8,788,000 | +28.6% | 777,625 | -0.1% | 0.02% | +28.6% |
| Q3 2014 | $6,833,000 | +8.0% | 778,244 | -10.3% | 0.01% | 0.0% |
| Q2 2014 | $6,325,000 | +23.0% | 867,651 | -15.0% | 0.01% | +16.7% |
| Q1 2014 | $5,143,000 | +218.3% | 1,020,532 | +237.3% | 0.01% | +200.0% |
| Q4 2013 | $1,616,000 | +41.8% | 302,578 | +0.9% | 0.00% | +33.3% |
| Q3 2013 | $1,140,000 | -43.5% | 300,000 | 0.0% | 0.00% | -50.0% |
| Q2 2013 | $2,019,000 | – | 300,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
| Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
| Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
| INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
| GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
| Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
| Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |